| Product Code: ETC12463397 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Russia Imatinib Drug Market Overview |
3.1 Russia Country Macro Economic Indicators |
3.2 Russia Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Russia Imatinib Drug Market - Industry Life Cycle |
3.4 Russia Imatinib Drug Market - Porter's Five Forces |
3.5 Russia Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Russia Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Russia Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Russia Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Russia Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Russia Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in prevalence of chronic myeloid leukemia (CML) in Russia |
4.2.2 Growing awareness about the benefits of imatinib therapy among healthcare professionals and patients in the region |
4.2.3 Favorable government initiatives and policies supporting access to innovative drugs like imatinib |
4.3 Market Restraints |
4.3.1 High cost associated with imatinib therapy leading to affordability issues for a significant portion of the population |
4.3.2 Stringent regulatory requirements and approval processes for new drugs in Russia |
4.3.3 Competition from generic imatinib products impacting market growth |
5 Russia Imatinib Drug Market Trends |
6 Russia Imatinib Drug Market, By Types |
6.1 Russia Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Russia Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Russia Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Russia Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Russia Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Russia Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Russia Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Russia Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Russia Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Russia Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Russia Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Russia Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Russia Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Russia Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Russia Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Russia Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Russia Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Russia Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Russia Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Russia Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Russia Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Russia Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Russia Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Russia Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Russia Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Russia Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Russia Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Russia Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Russia Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Russia Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Russia Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Russia Imatinib Drug Market Import-Export Trade Statistics |
7.1 Russia Imatinib Drug Market Export to Major Countries |
7.2 Russia Imatinib Drug Market Imports from Major Countries |
8 Russia Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib therapy |
8.2 Number of healthcare providers trained in prescribing and managing imatinib therapy |
8.3 Rate of successful treatment outcomes with imatinib therapy |
9 Russia Imatinib Drug Market - Opportunity Assessment |
9.1 Russia Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Russia Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Russia Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Russia Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Russia Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Russia Imatinib Drug Market - Competitive Landscape |
10.1 Russia Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Russia Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here